Crizotinib - multitargeted inhibitor in targeted NSCLC therapy

Abstract

Author presents an overview of pharmacology, indications, and therapeutic results of new targeted drug given in selected platients suffering from non-small cell lung cancer.

Keywords

• targeted therapy
• non-small cell lung cancer
• EML-4 ALK translocation